(Q33723589)

28 July 2017

Comparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pig. (English)

1 reference

28 July 2017

0 references

8

Petros C Karakousis

1 reference

28 July 2017

7

Jacques H Grosset

1 reference

28 July 2017

2

Eric L Nuermberger

1 reference

28 July 2017

Zahoor Ahmad

1

1 reference

28 July 2017

Rokeya Tasneen

3

1 reference

28 July 2017

Michael L Pinn

4

1 reference

28 July 2017

Kathy N Williams

5

1 reference

28 July 2017

Charles A Peloquin

6

1 reference

28 July 2017

language of work or name

English

0 references

publication date

31 January 2010

1 reference

Journal of Antimicrobial Chemotherapy

28 July 2017

1 reference

28 July 2017

65

1 reference

28 July 2017

4

1 reference

28 July 2017

729-734

1 reference

Biphasic kill curve of isoniazid reveals the presence of drug-tolerant, not drug-resistant, Mycobacterium tuberculosis in the guinea pig.

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837551

Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837551

Using animal models to develop new treatments for tuberculosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837551

Cavitary disease and quantitative sputum bacillary load in cases of pulmonary tuberculosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837551

Location of persisting mycobacteria in a Guinea pig model of tuberculosis revealed by r207910.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837551

Weekly moxifloxacin and rifapentine is more active than the denver regimen in murine tuberculosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837551

Isoniazid pharmacokinetics-pharmacodynamics in an aerosol infection model of tuberculosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837551

Moxifloxacin-containing Regimen Greatly Reduces Time to Culture Conversion in Murine Tuberculosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837551

The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837551

Four-month chemotherapy in the treatment of smear-negative pulmonary tuberculosis: results at 30 to 60 months.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837551

Present aspects of bacterial resistance in tuberculosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837551

Studies on the treatment of experimental tuberculosis of the guinea pig with intermittent doses of isoniazid

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837551

A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis. A twice-weekly, directly observed, and cost-effective regimen

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837551

Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837551

Bactericidal activity in vitro and in the guinea-pig of isoniazid, rifampicin and ethambutol

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837551

Addition of PNU-100480 to first-line drugs shortens the time needed to cure murine tuberculosis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837551

Altered expression of isoniazid-regulated genes in drug-treated dormant Mycobacterium tuberculosis

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837551

Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837551

Antimicrobial therapy of tuberculosis: justification for currently recommended treatment regimens

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837551

Streptomycin, a substance exhibiting antibiotic activity against gram-positive and gram-negative bacteria. 1944.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837551

Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837551

Population pharmacokinetic modeling of pyrazinamide in children and adults with tuberculosis

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837551

A controlled trial of a 2-month, 3-month, and 12-month regimens of chemotherapy for sputum smear-negative pulmonary tuberculosis: the results at 30 months. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council

30 October 2018

1 reference

12 December 2020

Isoniazid in experimental tuberculosis of guinea pigs infected with tubercle bacilli resistant to streptomycin and to para-aminosalicylic acid

1 reference

12 December 2020

Clinical and laboratory observations in Clostridium difficile colitis

1 reference

12 December 2020

A nested case-control study on treatment-related risk factors for early relapse of tuberculosis

1 reference

12 December 2020

Suitability of rifampicin for intermittent administration in the treatment of tuberculosis

1 reference

12 December 2020

The clinical pharmacokinetics of rifampin and ethambutol in HIV-infected persons with tuberculosis

1 reference

12 December 2020

Smear- and culture-negative pulmonary tuberculosis: four-month short-course chemotherapy

1 reference

12 December 2020

Identifiers

DOI

10.1093/JAC/DKQ007

1 reference

28 July 2017

1 reference

28 July 2017

1 reference